Events

For the first time, a dedicated panel on clinical trials will be featured at the Delphi Economic Forum, led and sponsored by HACRO, under the title “Clinical Trials in Europe: Competitiveness, Access and Innovation.” Delphi Economic Forum is one of the leading platforms for dialogue on the future of the economy, policy and innovation in

HACRO – the Hellenic Association of Contract Research Organizations – participated in the 52nd Annual Panhellenic Medical Congress, organised by the Athens Medical Society, held on 2–4 April. During the roundtable discussion “Patient Access to Innovation and the Role of Clinical Trials,” HACRO President Evangelia (Lia) Koraki highlighted the latest developments in the European and

HACRO – the Hellenic Association of Contract Research Organizations – participated in the 6th International Conference on Rare Diseases, organised by the Greek Rare Diseases Alliance (Rare Diseases Greece). HACRO President Evangelia (Lia) Koraki took part in the panel discussion “JARDIN – Strengthening Greece’s Role in ERNs and Clinical Trials (2026–2030)”, where she highlighted the

HACRO – the Hellenic Association of Contract Research Organizations – once again supported the Panhellenic Conference “Haematology as an Interdisciplinary Meeting Point: From the Algorithm to the Patient” organised in Ioannina by the Interdisciplinary Society for Research in Haematology, in collaboration with the Haematology Department of the University of Ioannina. HACRO President Evangelia (Lia) Koraki

Empowered patients play a vital role in shaping a modern, equitable and sustainable healthcare system. Through continuous education and access to reliable information, patients can actively participate in decisions regarding their treatment and care, while also contributing meaningfully to the development of effective health policies and the continuous improvement of healthcare services. In this context,

HACRO – the Hellenic Association of Contract Research Organizations – was delighted to welcome representatives of the government, healthcare and pharmaceutical institutions, the scientific community, the media and its member companies to its 2026 New Year’s Reception. The event reflected the shared commitment of all stakeholders to strengthening clinical research in Greece and fostering continued

HACRO – the Hellenic Association of Contract Research Organizations – participated in the scientific conference organised by the National Organisation for Medicines (EOF), which provided an important platform for institutional dialogue on the future of pharmaceutical policy in Greece. Representing HACRO, Board President Evangelia (Lia) Koraki took part in the panel discussion “Challenges and Proposals

HACRO – the Hellenic Association of Contract Research Organizations – was proud to support, under its auspices, the 10th Annual Conference of the Hellenic Cancer Federation (ELLOK), held under the theme “Putting People First – Building Bridges of Care.” HACRO President Evangelia (Lia) Koraki participated in the panel discussion “Clinical Trials: A Driving Force for

At the annual “Health Above All 2025” conference, co-organised by Next is Now and Dome Consulting, HACRO President Evangelia (Lia) Koraki participated in the panel discussion “Changing the Landscape: The New Era of Clinical Research,” alongside Lilian Vildiridi, Secretary General for Health Services, under the moderation of health journalist Aimilía Stathakou. The discussion highlighted the

HACRO President Evangelia (Lia) Koraki participated in the panel discussion “Artificial Intelligence, Clinical Trials and the Pharmaceutical Industry” at the 7th Panhellenic Conference on Clinical Trials and Research, organised by the Hellenic Association of Pharmaceutical Industry Representatives (SAFEE). During the discussion, Ms Koraki stressed that responsible innovation cannot exist without clinical trials. Clinical research is